Updated Oct. 20, 2009 at 8:35 a.m.

Premium Lock Durham firm develops intravenous H1N1 vaccine

Published: 2009-10-20 07:30:00
Updated: 2009-10-20 08:35:19

BioCryst BioCryst

BioCryst Pharmaceuticals Chief Executive Jon Stonehouse said its experimental drug Peramivir could be a tool to battle the H1N1 pandemic....

Read More
Read More

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders